-
Mashup Score: 2Treatment Adherence and Oncologic Outcomes in Rectal Cancer - 4 year(s) ago
This post hoc analysis of a randomized phase 3 trial analyzes the association of treatment adherence with disease-free survival among patients with rectal cancer in the CAO/ARO/AIO-04 trial.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Treatment Adherence and Oncologic Outcomes in Rectal Cancer - 4 year(s) ago
This post hoc analysis of a randomized phase 3 trial analyzes the association of treatment adherence with disease-free survival among patients with rectal cancer in the CAO/ARO/AIO-04 trial.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Treatment compliance to neoadjuvant 5-FU chemoradiotherapy with or without #Oxaliplatin is associated with clinical outcome in rectal #cancer whereas treatment compliance to adjuvant #chemotherapy is not https://t.co/f1vZcGdIT6
-
-
Mashup Score: 0Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin - 4 year(s) ago
Oxaliplatin causes a wider variety of immediate hypersensitivity reactions than do other platin-based chemotherapeutics. Some resemble type 1 reactions that respond to desensitization. Others are atypical, possibly mast cell–independent cytokine release reactions refractory to desensitization. Given this variability, clinicians need an evidence-based strategy to personalize therapy for…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Endophenotyping #Oxaliplatin #Hypersensitivity: Personalizing Desensitization to the #Atypical #Platin https://t.co/A6Pi9iERoc https://t.co/kUDzBGEi7J
-
Treatment compliance to neoadjuvant 5-FU chemoradiotherapy with or without #Oxaliplatin is associated with clinical outcome in rectal #cancer whereas treatment compliance to adjuvant #chemotherapy is not https://t.co/niT2YrEkqs